The above considerations motivate our hypothesis that modulating purine metabolism by inhibiting PNP activity would alter purine metabolism balance towards protective and away from harmful purines and thereby prevent or ameliorate organ damage in SCD [39]. The gene discussed is PNP; the disease is Schnyder corneal dystrophy.